Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature

Hanny Al-Samkari, MD, Alexandria Cronin, MLIS, Donald M. Arnold, MD MSc, Francesco Rodeghiero, MD, Rachael F. Grace, MD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-138694

Published: 2020

Journal Articles

Real-Life Management of Immune Thrombocytopenia in the Elderly: A Multicentre Study on 526 Patients

Blood (2018) 132 (Supplement 1): 2433.

https://doi.org/10.1182/blood-2018-99-114586

Published: 2018

Journal Articles

Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year

David J Kuter, MD DPhil, Adrian Newland, Beng H Chong, MBBS, PhD, Francesco Rodeghiero, MD, Monica Tejeda Romero, Ingrid Pabinger, MD, Yuqi Chen, Kejia Wang, Bhakti Mehta, Melissa Eisen

Blood (2017) 130 (Supplement 1): 1055.

https://doi.org/10.1182/blood.V130.Suppl_1.1055.1055

Published: 2017

Journal Articles

B-Cell Receptor Configuration and Adverse Cytogenetics Are Associated with Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia

Blood (2012) 120 (21): 1780.

https://doi.org/10.1182/blood.V120.21.1780.1780

Published: 2012

Journal Articles

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Reinhard Schneppenheim, MD, PhD, Ulrich Budde, MD, Javier Batlle, MD, Giancarlo Castaman, MD, Jeroen C. J. Eikenboom, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Tobias Obser, Florian Oyen, Francesco Rodeghiero, MD, Sonja Schneppenheim, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2012) 120 (21): 99.

https://doi.org/10.1182/blood.V120.21.99.99

Published: 2012

Journal Articles

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

Gianluigi Reda, MD, Francesco Maura, MD, Giuseppe Gritti, MD, Daniele Vincenti, MD, Mariarita Sciumé, MD, Nicola Orofino, MD, Anna Ines Gregorini, MD, Cristina Bucelli, MD, Francesca Binda, MD, Francesca Guidotti, MD, Alfonso Piciocchi, Francesco Rodeghiero, MD, Antonino Neri, Agostino Cortelezzi, MD

Blood (2012) 120 (21): 4598.

https://doi.org/10.1182/blood.V120.21.4598.4598

Published: 2012

Journal Articles

Risk Factors for Thrombosis Among 1,545 Patients with Polycythemia Vera: An International Study.

Guido Finazzi, MD, Elisa Rumi, MD, Alessandro M. Vannucchi, MD, Maria Luigia Randi, Ilaria Nichele, Heinz Gisslinger, MD, Rakhee Vaidya, MD, Mario Cazzola, Alessandro Rambaldi, MD, Lisa Pieri, MD, Francesco Rodeghiero, MD, Animesh Pardanani, MBBS, PhD, Juergen Thiele, Francesco Passamonti, MD, T Barbui, Ayalew Tefferi, MD

Blood (2012) 120 (21): 2849.

https://doi.org/10.1182/blood.V120.21.2849.2849

Published: 2012

Journal Articles

Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia Compared with the General Population

Fabio Efficace, Paola Fazi, Francesco Rodeghiero, MD, Gianluca Gaidano, MD, PhD, Piercarla Schinco, Monica Carpenedo, Alessandro Rambaldi, MD, Maria Pina Simula, Paolo De Fabritiis, Paolo Ditonno, Giovanni Caocci, MD, Salvatore Soldati, Alessandra Borchiellini, Erminia Baldacci, Julia Daragjati, Franco Mandelli, MD, Maria Gabriella Mazzucconi

Blood (2012) 120 (21): 2056.

https://doi.org/10.1182/blood.V120.21.2056.2056

Published: 2012

Journal Articles

Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients,

Blood (2011) 118 (21): 3846.

https://doi.org/10.1182/blood.V118.21.3846.3846

Published: 2011

Journal Articles

Sustained Hemostatic Platelet Counts in Adults with Immune Thrombocytopenia (ITP) Following Cessation of Treatment with the TPO Receptor Agonist Romiplostim: Report of 9 Cases,

James B Bussel, MD, Francesco Rodeghiero, MD, Roger M. Lyons, MD, Barry Firstenberg, Joanne Joseph, Craig M. Kessler, MD, Louis Terriou, Roberto Stasi, MD, PhD, Paul Chang, Susie Jun

Blood (2011) 118 (21): 3281.

https://doi.org/10.1182/blood.V118.21.3281.3281

Published: 2011

Journal Articles

Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year

Domenico Russo, Michele Baccarani, MD, Giovanni Martinelli, MD, Chiara Colombi, Michele Malagola, Cristina Skert, MD, Simona Soverini, Ilaria Iacobucci, PhD, Diamante Turri, MD, Salvatore Mirto, Marco Gobbi, MD, Ivana Pierri, Umberto Vitolo, MD, Patrizia Pregno, MD, Miriam Fogli, Nicoletta Testoni, Antonio De Vivo, Fausto Castagnetti, Enrica Morra, Ester Pungolino, Francesco Di Raimondo, MD, Fabio Stagno, Giuliana Alimena, Massimo Breccia, Francesco Nobile, MD, Bruno Martino, Alessandro Rambaldi, Tamara Intermesoli, Giuseppe Saglio, MD, Giovanna Rege Cambrin, Giuseppe Visani, Giuseppina Nicolini, Paolo de Fabritiis, Elisabetta Abruzzese, Renato Fanin, Mario Tiribelli, Piero Galieni, Catia Bigazzi, Giorgina Specchia, Emanuele Angelucci, Emilio Usala, Caterina Musolino, MD, Sabina Russo, Gianluca Gaidano, Monia Lunghi, M.D., Francesco Lauria, MD, Monica Bocchia, Francesco Rodeghiero, MD, Anna D'Emilio, Alberto Bosi, MD, Valeria Santini, MD, Giovanni Quarta, Mariella Girasoli, Giuseppe Fioritoni, MD, Roberto Di Lorenzo, Bruno Cesana, Gianantonio Rosti, MD

Blood (2011) 118 (21): 1682.

https://doi.org/10.1182/blood.V118.21.1682.1682

Published: 2011

Journal Articles

A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Blood (2011) 118 (21): 1746.

https://doi.org/10.1182/blood.V118.21.1746.1746

Published: 2011

Journal Articles

A Phase II Study of the HDAC Inhibitor Givinostat In Combination with Hydroxyurea In Patients with Polycythemia Vera Resistant to Hydroxyurea Monotherapy

Alessandro Rambaldi, Guido Finazzi, MD, Alessandro M. Vannucchi, MD, Vincenzo Martinelli, MD, Francesco Rodeghiero, MD, Francesco Nobile, MD, Giorgina Specchia, Enrico Maria Pogliani, MD, Odoardo Maria Olimpieri, MD, Giuseppe Fioritoni, MD, Caterina Musolino, MD, Giuseppe Saglio, MD, Piera Sivera, MD, Giovanni Barosi, MD, Silvia Di Tollo, MD, Tiziano Barbui, MD

Blood (2011) 118 (21): 1748.

https://doi.org/10.1182/blood.V118.21.1748.1748

Published: 2011

Journal Articles

Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-Cell Receptors

Francesco Maura, MD, Carlo Visco, MD, Elisabetta Novella, PhD, Ilaria Giaretta, PhD, Giacomo Tuana, PhD, Luca Agnelli, PhD, Marta Lionetti, PhD, Sonia Fabris, PhD, Francesca Guidotti, Gianluigi Reda, MD, Giuseppe Gritti, MD, Wilma Barcellini, MD, Luca Baldini, MD, Antonino Neri, MD, Francesco Rodeghiero, MD, Agostino Cortelezzi, MD

Blood (2011) 118 (21): 2847.

https://doi.org/10.1182/blood.V118.21.2847.2847

Published: 2011

Journal Articles

Survival and Prognosis Among 1,263 Patients with Polycythemia Vera: An International Study

Ayalew Tefferi, MD, Elisa Rumi, Guido Finazzi, MD, Alessandro M. Vannucchi, MD, Maria Luigia Randi, Ilaria Nichele, Heinz Gisslinger, MD, Rakhee Vaidya, MD, Mario Cazzola, Alessandro Rambaldi, Lisa Pieri, MD, Francesco Rodeghiero, MD, Irene Bertozzi, Bettina Gisslinger, Animesh Pardanani, MBBS, PhD, Juergen Thiele, Francesco Passamonti, MD, Tiziano Barbui, MD

Blood (2011) 118 (21): 277.

https://doi.org/10.1182/blood.V118.21.277.277

Published: 2011

Journal Articles

Sensitivity and Specificity of Laboratory Parameters to Detect Early/Prefibrotic Myelofibrosis in 857 Patients with Essential Thrombocythemia. A Diagnostic Algorithm

Alessandra Carobbio, MSc, Guido Finazzi, MD, Juergen Thiele, Hans-Michael Kvasnicka, Francesco Passamonti, MD, Elisa Rumi, Marco Ruggeri, MD, Francesco Rodeghiero, MD, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, MD, Elisabetta Antonioli, Heinz Gisslinger, MD, Veronika Buxhofer-Ausch, Naseema Gangat, MD, Alessandro Rambaldi, Ayalew Tefferi, MD, Tiziano Barbui, MD

Blood (2011) 118 (21): 5148.

https://doi.org/10.1182/blood.V118.21.5148.5148

Published: 2011

Journal Articles

Rituximab, Bendamustine and Cytarabine (R-BAC) Is a Very Active Regimen In Patients with Mantle Cell Lymphoma Not Eligible for Intensive Chemotherapy or Autologous Transplant

Carlo Visco, MD, Renato Zambello, Rossella Paolini, Silvia Finotto, Roberta Zanotti, Francesco Zaja, Gianpaolo Nadali, MD, Livio Trentin, Elisabetta Rodella, Laura Lissandrini, Gianpietro Semenzato, MD, Giovanni Pizzolo, Francesco Rodeghiero, MD

Blood (2011) 118 (21): 2677.

https://doi.org/10.1182/blood.V118.21.2677.2677

Published: 2011

Journal Articles

Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease

Daniel J. Hampshire, PhD, Lisa D. Bloomer, MSc, Ahlam M. Al-Buhairan, PhD, Rachael E. Coyle, Raymon N. C. P. Vijzelaar, MSc, David Lillicrap, MD, Paula D. James, MD, Jeroen C. J. Eikenboom, MD, PhD, Reinhard Schneppenheim, MD, PhD, Francesco Rodeghiero, MD, Robert R. Montgomery, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2010) 116 (21): 2218.

https://doi.org/10.1182/blood.V116.21.2218.2218

Published: 2010

Journal Articles

Survival and Risk of Leukemic transformation in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study on 1,104 Patients

Blood (2010) 116 (21): 457.

https://doi.org/10.1182/blood.V116.21.457.457

Published: 2010

Journal Articles

The Effects of Romiplostim or Standard of Care (SOC) on Splenectomy and Treatment Failure of Patients Who Had Immune Thrombocytopenia (ITP) for Less Than or Equal to One Year.

Ralph Boccia, MD, David J. Kuter, MD, DPhil, Mathias J. Rummel, MD, PhD, B. Gail Macik, MD, Ingrid Pabinger, MD, Dominik Selleslag, MD, Francesco Rodeghiero, MD, Beng Chong, MBBS, PhD, Xuena Wang, PhD, Richard Lizambri, MD

Blood (2010) 116 (21): 3702.

https://doi.org/10.1182/blood.V116.21.3702.3702

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature

Real-Life Management of Immune Thrombocytopenia in the Elderly: A Multicentre Study on 526 Patients

Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year

B-Cell Receptor Configuration and Adverse Cytogenetics Are Associated with Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

Risk Factors for Thrombosis Among 1,545 Patients with Polycythemia Vera: An International Study.

Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia Compared with the General Population

Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients,

Sustained Hemostatic Platelet Counts in Adults with Immune Thrombocytopenia (ITP) Following Cessation of Treatment with the TPO Receptor Agonist Romiplostim: Report of 9 Cases,

Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year

A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

A Phase II Study of the HDAC Inhibitor Givinostat In Combination with Hydroxyurea In Patients with Polycythemia Vera Resistant to Hydroxyurea Monotherapy

Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-Cell Receptors

Survival and Prognosis Among 1,263 Patients with Polycythemia Vera: An International Study

Sensitivity and Specificity of Laboratory Parameters to Detect Early/Prefibrotic Myelofibrosis in 857 Patients with Essential Thrombocythemia. A Diagnostic Algorithm

Rituximab, Bendamustine and Cytarabine (R-BAC) Is a Very Active Regimen In Patients with Mantle Cell Lymphoma Not Eligible for Intensive Chemotherapy or Autologous Transplant

Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease

Survival and Risk of Leukemic transformation in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study on 1,104 Patients

The Effects of Romiplostim or Standard of Care (SOC) on Splenectomy and Treatment Failure of Patients Who Had Immune Thrombocytopenia (ITP) for Less Than or Equal to One Year.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only